# CURRENT STATUS: Active Medical Crisis
*Last Updated: June 4, 2025*

---

## ðŸš¨ **IMMEDIATE MEDICAL SITUATION**

**Current Crisis Phase:** 5+ weeks of accelerated neurological deterioration*  
**Disease Duration:** 5 years, 7 months, 24 days (November 10, 2019 - June 4, 2025)**  
**Pattern Shift:** Episodic (72-hour cycles) â†’ persistent daily dysfunction***  
**Laboratory Paradox:** Best lab values in years concurrent with worst neurological symptoms****  

*[Patient-Documentation-May2025-Crisis-Timeline] **[Timeline-Calculation-Nov2019-Jun2025] ***[Pattern-Analysis-Episodic-to-Persistent] ****[GFC-LAB-Jan21,2025-vs-Current-Symptoms]

---

## âš¡ **ACTIVE SYMPTOMS REQUIRING IMMEDIATE ATTENTION**

### **Neurological Crisis Symptoms:**
1. **Loss of automatic respiratory drive** - requiring conscious effort to breathe*
2. **Daily autonomic instability** - tachycardia >100 BPM, pre-syncope episodes**
3. **Progressive tremor syndrome** - generalized tremors with vocal involvement***
4. **Neurovascular events** - left ear phenomena, occipital pressure sensations****
5. **Positional triggers** - bending/position changes causing neurological crises*****
6. **Motor system dysfunction** - progressive freeze states affecting feeding/mobility******

*[BHS-ER-May26,2025-Chief-Complaint] **[Patient-Daily-Documentation-Autonomic-Episodes] ***[Urgent-Care-May22,2025-Tremor-Documentation] ****[Patient-Documentation-May7-May23-Neurovascular-Events] *****[Patient-Documentation-Jun2,2025-Positional-Event] ******[Patient-Documentation-Freeze-States]

---

## ðŸ“Š **CURRENT MEASURABLE DYSFUNCTION**

### **Autonomic System Metrics (May 2025 - Oura Ring Validation):**
- **HRV Severe Decline:** May 13: 15, May 14: 14, May 24: 18, May 26 (ER day): 16 (50-70% below normal 30-60+)*
- **Baseline HR elevation:** Historical 72-75 BPM â†’ Current 68-86 BPM range**
- **May 26 (ER crisis day):** Resting HR 81.92 BPM (elevated during crisis)***
- **Post-micturition HR spike:** 80s â†’ 107 BPM within 2 minutes (34% increase)****
- **Daily tachycardia episodes:** >100 BPM multiple times daily*****
- **Temperature deviations:** Persistent elevations (May 13: +0.38Â°C, May 16: +0.24Â°C, May 26: +0.17Â°C)******
- **Sleep disruption:** Rigid 4:00 AM awakening pattern*******

*[Oura-Trends-Data-May2025-HRV-Crash-Documentation] **[Oura-Trends-Data-May2025-HR-Range] ***[Oura-Trends-Data-May26-ER-Day-HR] ****[Patient-Home-Testing-May9,2025-Autonomic-Response] *****[Patient-Daily-Documentation-Tachycardia] ******[Oura-Trends-Data-May2025-Temperature-Validation] *******[Patient-Documentation-Sleep-Pattern]

### **Respiratory Monitoring (June 2025 - Wellue Ring Precision Data):**
**June 4, 2025 (7:58am-3:08pm):**
- **Minimum O2:** 72% (severe, life-threatening desaturation)*
- **O2 Score:** 5.5 (severely abnormal)**
- **Drops >4%:** 38 events in 7+ hours***

**June 3, 2025 (overnight 10:56pm-6:39am):**
- **Minimum O2:** 79% (significant desaturation)****
- **O2 Score:** 7.2*****
- **Drops:** 16 events during sleep******

**June 1, 2025 (daytime 10:50am-8:39pm):**
- **Minimum O2:** 85% (significant desaturation)*******
- **O2 Score:** 6.3 (severely abnormal)********
- **Drops >4%:** 64 events in 9+ hours (6.51-9.66 per hour)*********

**Clinical Significance:** Objective validation of respiratory control dysfunction with life-threatening oxygen desaturations during routine activities**********

*-**********[Wellue-Ring-Precision-Data-Jun2025-Unaveraged-Measurements]

---

## ðŸ§ª **LABORATORY-CLINICAL PARADOX**

### **Best Laboratory Values in 5+ Years (January 2025):**
- **WBC:** 7.5 K/uL (optimal range for first time since 2019)*
- **Hemoglobin:** 13.6 g/dL (normalized from progressive anemia)**
- **MCHC:** 34.0 g/dL (recovered)***
- **Glucose:** 88 mg/dL (optimal control)****
- **ALT:** 18 U/L (baseline normal)*****

### **Concurrent Worst Neurological Symptoms:**
- **Daily autonomic crises** vs. recovered immune function******
- **New symptom categories** (respiratory control loss, vocal tremors)*******
- **Progressive motor dysfunction** vs. normalized blood counts********
- **Accelerated event frequency** vs. optimal metabolic function*********

**Clinical Significance:** Transition from inflammatory to structural/functional neurological pathophysiology**********

*-*****[GFC-LAB-Jan21,2025-Complete-Panel] ******-*********[Patient-Daily-Documentation-vs-Laboratory-Recovery] **********[Pattern-Analysis-Pathophysiology-Transition]

---

## ðŸ“… **RECENT CRITICAL EVENTS**

### **May 26, 2025 - Emergency Department Crisis:**
**Primary Complaint:** Loss of automatic respiratory drive*  
**Secondary Symptoms:** Severe tremors, altered consciousness, myoclonic jerks**  
**Laboratory Abnormalities:** Sodium 136 mmol/L (LOW), ALT 74 U/L (HIGH), AST 65 U/L (HIGH)***  
**ECG Finding:** "ABNORMAL ECG - PROBABLE ANTEROSEPTAL INFARCT, OLD"****  

*[BHS-ER-May26,2025-Chief-Complaint] **[BHS-ER-May26,2025-Secondary-Symptoms] ***[BHS-ER-May26,2025-Laboratory-Results] ****[BHS-ER-May26,2025-ECG]

### **June 2, 2025 - Positional Trigger Event:**
**Trigger:** Bending at waist while cleaning*****  
**Response:** Lightning sensation at skull base, HR spike to 130+ BPM******  
**Duration:** 45 minutes primary symptoms, residual occipital "static"*******  
**Significance:** Rapid functional decline from weeks prior********  

*****-********[Patient Documentation-June2,2025-Complete Event]

### **June 4, 2025 - Brain MRI Results:**
**Key Findings:**
- **Normal pituitary gland** - no evidence of mass*********
- **No acute stroke, hemorrhage, or mass lesion**********
- **Nonspecific fluid at right mastoid air cells** (warrants investigation)***********
- **Functional vs. structural:** Suggests brainstem dysfunction is functional************

*********-************[Benefis MRI Report-June4,2025-Complete Findings]

---

## ðŸ’Š **CURRENT MEDICATION REGIMEN (14 Daily Medications)**

### **Neurological/Psychiatric:**
- Klonopin 1mg QHS, Lamictal 150mg AM, Seroquel 50mg QHS*
- Zoloft 150mg AM, Adderall XR 30mg BID, Gabapentin 300mg BID**

### **Gastrointestinal:**
- Pantoprazole 40mg AM, Pepcid daily, Dicyclomine PRN***

### **Other:**
- Flovent BID, Albuterol PRN, NuvaRing continuous****
- Vitamin D3, Magnesium, Quercetin+C, Multivitamin*****
- Nystatin oral rinse BID (thrush treatment)******

### **Recent Changes:**
- **Seroquel reduced:** 75mg â†’ 50mg (~2 weeks prior to crisis)*******
- **Fluconazole course:** May 23-June 6, 2025 (ER crisis 3 days after start)********

*-******[Current Medication List-June2025] *******[Patient Documentation-Seroquel Reduction] ********[BHS-ER-May26,2025-Fluconazole Timeline]

---

## ðŸŽ¯ **IMMEDIATE CLINICAL PRIORITIES**

### **Critical Safety Alert:**
- **72% oxygen saturation** documented June 4, 2025 - borderline life-threatening level*********
- **Frequent severe desaturations** across multiple days (64 drops in single session)**********
- **Progressive respiratory dysfunction** with objective validation***********
- **Immediate pulmonology consultation** warranted************

*********-************[Wellue Ring-Critical O2 Documentation June 2025]

### **Urgent Neurological Evaluation:**
1. **Craniocervical junction imaging** - positional triggers + hypermobility*************
2. **MR angiography posterior circulation** - neurovascular events**************
3. **CSF flow studies** - mastoid fluid finding evaluation***************
4. **Brainstem-focused MRI** - respiratory control dysfunction****************
5. **Autonomic function testing** - tilt table, QSART*****************

*************-*****************[PME-Recommendations-Urgent Neurological Workup]

---

## ðŸ“‹ **FUNCTIONAL STATUS**

### **Significantly Impaired:**
- **Bending/positional changes** trigger neurological crises******************
- **Independent eating** compromised by freeze states*******************
- **Extended activities** cause rapid functional decline******************** 
- **Sleep regulation** completely disrupted*******************

### **Preserved Functions:**
- **Cognitive clarity** between episodes********************
- **Self-advocacy** and sophisticated medical analysis*********************
- **Documentation ability** maintains research-quality tracking**********************

******************-**********************[Functional Assessment-Current Status]

---

## ðŸ”® **PROGNOSIS & TRAJECTORY**

### **Short-term (Days-Weeks):**
- **Symptom stability:** Unlikely without intervention***********************
- **Crisis risk:** High for autonomic/respiratory episodes************************
- **Intervention window:** Immediate evaluation needed*************************

### **Research Collaboration Potential:**
- **Active disease documentation** with real-time progression capture**************************
- **5+ year baseline data** eliminating typical research collection phase***************************
- **Research partnership willing** for continued systematic documentation****************************

***********************-****************************[Prognosis Assessment-Current Crisis]

---

**Current Status:** âœ… Active neurological crisis with life-threatening respiratory dysfunction  
**Monitoring Enhancement:** Wellue ring providing precision O2 data showing 72% desaturations  
**Research Value:** Objective validation of respiratory control dysfunction  
**Provider Priority:** IMMEDIATE pulmonology and specialized neurological evaluation  
**Next Update:** Integration of additional Wellue precision respiratory data

*Current status compiled from: Patient daily documentation (May-June 2025), Emergency department records (May 26, 2025), Oura ring objective validation (May 2025), Wellue ring precision O2 monitoring (June 2025), Brain MRI results (June 4, 2025), Real-time neurological event documentation*
